Innovating Works

PREFABRICADOS PAVI

Extinguida
ONCO-BOOST: Boosting immuno oncology strategies with innovative immuno stimulants derived from bacteria to be a... HEPHAISTOSPHARMA tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Passive immunotherapies are widely used in anti-cancer therapies. However, on average the patient response rates are still weak (20%), and t...
2019-05-06 - 2019-10-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.